Literature DB >> 12437333

Species differences in the in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine.

Ge Lin1, Yan-Yan Cui, Xiao-Quan Liu, Zhen-Tao Wang.   

Abstract

Clivorine is a representative naturally occurring hepatotoxic otonecine-type pyrrolizidine alkaloid. Our previous study has demonstrated that clivorine induces liver damage via metabolic activation to form the reactive pyrrolic ester followed by covalent binding to liver tissue constituents. The present study investigated species differences in the in vitro metabolic activation of clivorine in the male rat and guinea pig of both sexes. In the male rat, the activation of clivorine to form the reactive pyrrolic ester was found as the only metabolic pathway. Moreover, the toxic tissue-bound pyrroles and four isolatable metabolites identified, namely DHR, 7-GSH-DHR, 7,9-diGSH-DHR, and clivoric acid, were all generated from further metabolism of this reactive intermediate. In the case of both sexes of guinea pig, the same activation was observed as the minor biotransformation, while an additional metabolic pathway, a direct hydrolysis of clivorine to form novel clivopic acid was identified as the predominant detoxification pathway. Furthermore, the formation rates for the toxic tissue-bound pyrroles and less toxic DHR were significantly slower and higher, respectively, compared with those in the male rat. In addition, the formation of the reactive pyrrolic ester was mediated by the CYP3A subfamily in both animals, while carboxylesterases might be responsible for the detoxification hydrolysis in guinea pig. The results suggest that the higher metabolic rates for detoxification hydrolyses and the lower formation rate for the toxic tissue-bound pyrroles play the key roles in guinea pig resistance to clivorine intoxication. Therefore, the male rat and guinea pig should be the suitable animal models for further studies of bioactivation and deactivation of otonecine-type PA, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437333     DOI: 10.1021/tx0255370

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  7 in total

1.  Metabolism, genotoxicity, and carcinogenicity of comfrey.

Authors:  Nan Mei; Lei Guo; Peter P Fu; James C Fuscoe; Yang Luan; Tao Chen
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2010-10       Impact factor: 6.393

2.  Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine, a hepatotoxic pyrrolizidine alkaloid.

Authors:  Aizhen Xiong; Fan Yang; Lianxiang Fang; Li Yang; Yuqi He; Yu-Jui Yvonne Wan; Yvonne Yu-Jui Wan; Ying Xu; Meng Qi; Xiuli Wang; Kate Yu; Karl Wah-Keung Tsim; Zhengtao Wang
Journal:  Chem Res Toxicol       Date:  2014-04-01       Impact factor: 3.739

Review 3.  Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids.

Authors:  Yisheng He; Lin Zhu; Jiang Ma; Ge Lin
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

4.  The Role of Astrocytes in Metabolism and Neurotoxicity of the Pyrrolizidine Alkaloid Monocrotaline, the Main Toxin of Crotalaria retusa.

Authors:  Bruno Penas Seara Pitanga; Ravena P Nascimento; Victor Diógenes A Silva; Silvia L Costa
Journal:  Front Pharmacol       Date:  2012-08-03       Impact factor: 5.810

5.  In vitro and in vivo metabolism and inhibitory activities of vasicine, a potent acetylcholinesterase and butyrylcholinesterase inhibitor.

Authors:  Wei Liu; Xiaoyuan Shi; Yadi Yang; Xuemei Cheng; Qing Liu; Han Han; Baohua Yang; Chunyong He; Yongli Wang; Bo Jiang; Zhengtao Wang; Changhong Wang
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

6.  In vitro biotransformation of pyrrolizidine alkaloids in different species. Part I: Microsomal degradation.

Authors:  Franziska Kolrep; Jorge Numata; Carsten Kneuer; Angelika Preiss-Weigert; Monika Lahrssen-Wiederholt; Dieter Schrenk; Anja These
Journal:  Arch Toxicol       Date:  2017-11-16       Impact factor: 5.153

7.  Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.

Authors:  Fang Liu; Xinxin Rong; Hui Guo; Dong Xu; Chang Liu; Lingling Meng; Xiaoqian Yang; Tingting Guo; Xuefeng Kan; Yuhu Song
Journal:  BMC Gastroenterol       Date:  2020-02-04       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.